HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Javier Cañueto Selected Research

Nonsense Codon (Nonsense Mutation)

7/2011Buschke-Ollendorff syndrome with striking phenotypic variation resulting from a novel c.2203C>T nonsense mutation in LEMD3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Javier Cañueto Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 05/2019
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 05/2019
3Melanoma (Melanoma, Malignant)
06/2021 - 12/2013
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2024 - 01/2023
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2023 - 12/2018
2Hidradenitis Suppurativa
01/2023 - 05/2019
2Chondrodysplasia Punctata (Stippled Epiphyses)
03/2015 - 03/2014
1Lymphoma (Lymphomas)
01/2023
1Basal Cell Carcinoma (Rodent Ulcer)
01/2023
1Netherton Syndrome
01/2023
1Skin Neoplasms (Skin Cancer)
05/2019
1Erythema
05/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2015
1Skin Diseases (Skin Disease)
09/2014
1Paralysis (Palsy)
12/2013
1Follicular Mucinosis
11/2013
1Renal Cell Carcinoma (Grawitz Tumor)
11/2013
1Actinic Keratosis
11/2013
1Purpura
07/2012
1Sclerema Neonatorum
07/2012
1Thrombocytopenia (Thrombopenia)
07/2012
1Hemolytic-Uremic Syndrome
07/2012
1Thrombotic Microangiopathies
07/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2012
1Scleromyxedema (Lichen Myxedematosus)
05/2012
1Rare Diseases (Rare Disease)
05/2012
1Buschke-Ollendorff syndrome
07/2011
1Amyloidosis
02/2010

Drug/Important Bio-Agent (IBA)

2Clindamycin (Cleocin)FDA LinkGeneric
01/2023 - 05/2019
2Rifampin (Rifampicin)FDA LinkGeneric
01/2023 - 05/2019
2Brentuximab VedotinIBA
01/2023 - 12/2018
2InterferonsIBA
12/2021 - 03/2015
2MucinsIBA
09/2014 - 11/2013
1Janus Kinase InhibitorsIBA
01/2024
1Interleukin-17 (Interleukin 17)IBA
01/2024
1HhAntag691IBA
01/2023
1dupilumabIBA
01/2023
1Proteins (Proteins, Gene)FDA Link
01/2022
1Nucleic AcidsIBA
01/2022
1VaccinesIBA
10/2021
1Immune Checkpoint InhibitorsIBA
06/2021
1NivolumabIBA
06/2021
1IpilimumabIBA
06/2021
1MicroRNAs (MicroRNA)IBA
05/2019
1Carrier Proteins (Binding Protein)IBA
03/2015
1emopamil (levemopamil)IBA
03/2015
1CholesterolIBA
03/2014
1Infliximab (Remicade)FDA Link
12/2013
1Sunitinib (Sutent)FDA Link
11/2013
1GemcitabineFDA Link
07/2012
1AntimetabolitesIBA
07/2012
1DeoxycytidineIBA
07/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2012
1Bortezomib (Velcade)FDA Link
05/2012
1Nonsense Codon (Nonsense Mutation)IBA
07/2011
1Amyloid (Amyloid Fibrils)IBA
02/2010

Therapy/Procedure

7Therapeutics
01/2023 - 05/2012
2Radiotherapy
01/2023 - 10/2021
2Immunotherapy
10/2021 - 06/2021
1Hematopoietic Stem Cell Transplantation
06/2023
1Defibrillators (Defibrillator)
05/2018